Question 1
What is the next step in the management of severe coarctation of the aorta in a newborn?
Correct Answer:
IV prostaglandin E1
Explanation:
In the management of severe coarctation of the aorta in a newborn, initiating IV prostaglandin E1 is a critical next step. This medication serves to maintain ductal patency, which is essential in cases of coarctation where systemic and pulmonary blood flow may be compromised. In the context of aortic coarctation, especially in neonates, the condition can lead to severe complications if the blood supply to the lower body is restricted. Prostaglandin E1 works by keeping the ductus arteriosus open, thus allowing for collateral circulation to develop and ensuring that blood flow can reach the lower extremities and vital organs. This is particularly crucial in cases of critical coarctation, where the newborn may be at risk for significant end-organ dysfunction. Once stabilized with prostaglandin E1, further definitive treatment, such as surgical intervention or other approaches, can be planned based on the clinical scenario and the infant's overall condition. The use of IV antibiotics, while important in other contexts such as sepsis, does not address the urgent hemodynamic needs associated with coarctation. Immediate surgery may be necessary in some cases, but it would typically follow stabilization with prostaglandin E
Question 2
What finding in direct immunofluorescence can show inflammatory activity in the skin?
Correct Answer:
Linear IgG deposits
Explanation:
The presence of linear IgG deposits seen in direct immunofluorescence is indicative of ongoing inflammatory activity in the skin, particularly in the context of autoimmune blistering diseases, such as pemphigus vulgaris or bullous pemphigoid. In these diseases, IgG antibodies target specific components of the skin, leading to a characteristic linear pattern of deposition along the basement membrane zone. This pattern is associated with significant inflammatory response and blister formation. In the context of pemphigoid, for example, the linear IgG deposits point to the binding of antibodies to hemidesmosome proteins, leading to dermal-epidermal separation, which manifests as blisters. The detection of these antibodies highlights the underlying pathophysiological processes that contribute to the inflammation and clinical symptoms observed in these conditions. Other potential findings, such as granular IgA deposits, fibrinogen at the dermal-epidermal junction, and the presence of IgE in the papillary dermis, can reflect different types of dermatologic conditions or processes, but they do not directly signify acute inflammatory activity in the same manner as linear IgG deposits do in the context of autoimmune dermatoses.
Question 3
Which organism is commonly responsible for acute infectious lymphangitis?
Correct Answer:
Streptococcus pyogenes or MSSA
Explanation:
Acute infectious lymphangitis is commonly caused by Streptococcus pyogenes, a β-hemolytic streptococcus known for its role in skin and soft tissue infections, particularly following skin breaks. This organism is capable of rapidly spreading through the lymphatic system, leading to the characteristic symptoms of lymphangitis such as red streaking along the lymphatic vessels, fever, and local pain or tenderness. In some cases, Methicillin-sensitive Staphylococcus aureus (MSSA) can also be involved in the condition, particularly in patients with skin infections or other predisposing factors. The pathogenesis involves bacterial entry through a cut or abrasion, triggering an inflammatory response in the lymphatic channels. Streptococcus pyogenes is particularly efficient at this, as it can adhere to and invade host cells, causing necrosis and suppuration, ultimately leading to lymphatic inflammation. While other organisms such as Escherichia coli, Staphylococcus epidermidis, and Clostridium perfringens may be involved in different types of infections or conditions, they are not typical pathogens associated with acute infectious lymphangitis. E. coli is more often implicated in urinary tract infections or intestinal diseases, Staphylococcus epidermidis is typically a skin
Question 4
What pattern of lymphadenopathy is associated with follicular lymphoma?
Correct Answer:
Waxing and waning or slowly progressing LAD
Explanation:
Follicular lymphoma is characterized by a specific pattern of lymphadenopathy that generally presents as waxing and waning or slowly progressing lymphadenopathy. This indolent cancer originates from B lymphocytes and typically exhibits a more gradual increase in lymph node size rather than an acute or rapid enlargement. Patients may experience periods where their lymphadenopathy appears to improve or stabilize, followed by phases of progression. This pattern reflects the nature of follicular lymphoma as a low-grade non-Hodgkin lymphoma, which can often escape immediate detection and may not present symptoms until it has reached a more advanced stage. In contrast, progressive lymphadenopathy suggests a more aggressive disease process and may align more with other lymphomas, while rapidly enlarging lymphadenopathy would be indicative of a more aggressive malignancy such as diffuse large B-cell lymphoma. Localized lymphadenopathy does not fit the typical pattern seen in follicular lymphoma, as this condition often involves multiple lymph node regions rather than being confined to a single area. This highlights the subtle but important clinical features of follicular lymphoma in distinguishing it from other forms of lymphatic malignancies.
Question 5
Which x-ray finding is characteristic of osteosarcoma?
Correct Answer:
Destruction of medullary and cortical bone
Explanation:
Osteosarcoma is a type of malignant bone tumor that typically affects the long bones, particularly around the knee (distal femur and proximal tibia). A hallmark of osteosarcoma on an X-ray is the destruction of both the medullary (inner) and cortical (outer) bone. This radiographic finding reflects the aggressive nature of the tumor and its ability to invade the surrounding bone structure. In osteosarcoma, one can also see a characteristic "sunburst" pattern of bone formation or periosteal reaction due to the rapid bone growth associated with the tumor. However, the destruction of normal bone architecture—both of the medullary cavity and cortex—is essential for the diagnosis. This destructive process often leads to a mixed lytic and blastic appearance on imaging, which is very distinct compared to other conditions. While the other answer choices may relate to various bone or soft tissue conditions, they do not specifically represent the typical imaging findings associated with osteosarcoma. For instance, fractured bones can appear in several different scenarios, calcification in soft tissue can suggest other pathologies such as dystrophic calcification or calcifying tumors, and joint effusion is often seen with injury or inflammatory conditions but is not indicative
Question 1
Exam overview

About this Exam

The COMLEX-USA Level 2-CE is a major milestone for osteopathic medical students. This examination assesses whether a candidate possesses the clinical knowledge and application skills required to begin supervised patient care in a residency program. As the second level of the licensing series, it is designed for students who have completed their core clinical rotations. Passing this test demonstrates readiness to transition from student to resident physician.

More details

Additional Information

What the Course Entails and Exam Details

While not a course itself, the COMLEX Level 2-CE assesses proficiency across all core medical disciplines. The blueprint focuses heavily on the application of clinical science knowledge with an emphasis on osteopathic philosophy.

The core subject areas include Internal Medicine, Surgery, Pediatrics, Obstetrics and Gynecology, Family Medicine, Psychiatry, Emergency Medicine, and Osteopathic Principles and Practice (OPP/OMM).

You will be evaluated on your ability to make appropriate patient management decisions through data acquisition, interpretation, and treatment planning.

The examination integrates foundational biomedical sciences with clinical presentations commonly encountered in supervised clinical settings.


What to Expect in the Final Exam

The COMLEX Level 2-CE is a one-day, computer-based examination. It consists of 352 single-best-answer multiple-choice questions.

The total testing time is eight hours, divided into two four-hour sessions.

Candidates are provided with a pool of 60 minutes for breaks, which are taken between sections.

Individual sections are self-paced, but once you close a section, you cannot return to it.

Scoring is calculated on a standard score scale, and candidates must achieve the established passing score set by the NBOME to receive credit.

The exam also features audiovisual elements, such as images, videos, and audio clips.


How to Study and Exam Centers

Effective preparation requires a balanced approach of practice questions and content review.

Utilize comprehensive question banks specifically designed for COMLEX to become familiar with the clinical scenario format and OMM integration.

Active review using spaced repetition software or high-yield medical summaries is recommended.

Candidates are encouraged to take official NBOME practice exams (COMSAE) to simulate test conditions and identify weak areas.

To take the examination, you must register through your NBOME account. The exam is administered at secure Pearson VUE testing centers located throughout North America. It is crucial to schedule your appointment well in advance to secure your preferred date and location.


Job Opportunities from the Course

Passing the COMLEX Level 2-CE is not a terminal certification for employment itself; rather, it is a mandatory prerequisite for licensure as an Osteopathic Physician. Successfully completing this exam unlocks the necessary pathway to your desired medical career. The direct opportunities this achievement facilitates include:

Residency Physician (entering accredited DO or MD residency programs)

Fellow Physician (after residency completion)

Licensed Physician in All Medical Specialties (after passing Level 3)

Hospitalist

Primary Care Physician

Medical Educator

Healthcare Administrator

Clinical Researcher


Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions